Comment: Laparoscopic versus open resection for colorectal liver metastases
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
13 Jun 2019
CheckMate-142: Updated data from MSI high metastatic colon cancer patients
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
13 Jun 2019
VOLFI trial final results: mFOLFOXIRI and panitumumab versus FOLFOXIRI in ECOG 0...
Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany
10 Jun 2019
Highlights from ASCO 2019
Asst. Prof Bishal Gyawali and Monique Biryiana
3 Jun 2019
Long-term survival after laparoscopic versus open resection for colorectal liver...
Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway
3 Jun 2019
No difference in survival between laparoscopic surgery and open surgery in color...
Dr Åsmund Fretland - Oslo University Hospital, Oslo, Norway
3 Jun 2019
Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer wi...
Prof Arnaud Mejean - Paris Descartes University, Paris, France
3 Jun 2019
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitin...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
1 Jun 2019
KEYNOTE-062 study: Pembrolizumab as treatment for advanced gastroesophageal junc...
Dr Josep Tabernero - Vall d’Hebron Barcelona University Hospital, Barcelona, Spa...
1 Jun 2019
Comment: Reasonable to conclude that pembrolizumab is non-inferior to chemothera...
Dr Richard Schilsky and Dr Josep Tabernero
1 Jun 2019
Pembrolizumab comparable to chemotherapy for patients with advanced gastric or g...
Dr Josep Tabernero - Vall d’Hebron Barcelona University Hospital , Barcelona, Sp...
1 Jun 2019
IMPACT: Improving Management of Advanced Colorectal Tumours
Mr Steve Clark, Patient Advocate for Bowel Cancer UK and Expert Patient for ACPG...
21 May 2019
